Welcome to our dedicated page for Innventure SEC filings (Ticker: INV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Innventure, Inc. (NASDAQ: INV) SEC filings page on Stock Titan provides access to the company’s official U.S. Securities and Exchange Commission documents, along with AI-powered summaries that explain their contents in plain language. These filings are central to understanding how Innventure structures its industrial growth conglomerate model, finances its operations, and governs its family of technology-driven businesses.
Innventure’s recent Form 8-K current reports describe material events such as securities purchase agreements for convertible debentures with YA II PN, Ltd. (Yorkville), private placements of common stock and warrants, changes in independent registered public accounting firms, and the appointment of its first Lead Independent Director. Other 8-Ks detail financing arrangements and governance rights related to Accelsius Holdings LLC, Innventure’s controlled subsidiary focused on data center cooling products.
The company’s registration statements, including Form S-1 and shelf registration on Form S-3, outline its capital structure, preferred stock designations, and the registration of common shares and warrant shares for resale. Definitive proxy materials on Schedule 14A explain proposals submitted to stockholders, such as approvals needed under Nasdaq listing rules for issuing 20% or more of outstanding common stock in connection with convertible debentures and equity purchase agreements.
On this page, users can also monitor proxy statements, special meeting notices, and related voting information that describe how Innventure seeks shareholder approval for key financing transactions. For subsidiary-level financing, filings discuss convertible notes, preferred units, and rights granted to strategic investors in Accelsius.
Stock Titan’s interface surfaces these filings in real time from EDGAR and enhances them with AI-generated highlights, helping readers quickly identify important terms such as conversion prices, voting rights, index inclusion effects, and changes in auditor or board structure without needing to parse every technical detail themselves.
Innventure, Inc. is highlighting major operating and financial milestones that it believes show accelerating momentum across its portfolio companies and a stronger capital outlook. The business reports more than $50 million in Q1 2026 bookings from its operating companies, which it presents as a commercial inflection point.
Accelsius is projected to become cash flow positive by year-end 2026, supported by a sales pipeline exceeding $1 billion and planned deployments of its NeuCool® MR250 system, including a large AI data center project in Canada. AeroFlexx and Refinity are launching their own capital raises as they reach commercial and technical milestones, which, together with falling general and administrative expenses and a prior $40 million registered direct offering in January 2026, are expected to materially reduce corporate capital needs and put Innventure on a path to consolidated cash flow positivity in 2028.
The company also plans governance enhancements, with its Board adding two new independent directors and reducing management directors over time, aiming to strengthen independent oversight and align more closely with public-company governance standards.
Innventure, Inc. reported that executive officers Michael Otworth and John Scott had shares of common stock withheld to cover tax obligations from vested restricted stock units settled on February 26, 2026. The number of shares withheld was based on the closing price of the stock on the settlement date and did not involve any open market sales by the executives.
The withholding was non-discretionary, approved under Rule 16b-3, and carried out according to the RSU award agreements, making it exempt from Section 16(b). After these transactions, Mr. Otworth beneficially owns 3,274,030 shares and Dr. Scott beneficially owns 1,814,998 shares, indicating continued significant ownership in the company.
Innventure, Inc. Chief Strategy Officer Scott John Stewart reported a tax-withholding disposition of 150,053 shares of common stock at $2.80 per share. The shares were withheld to cover tax obligations related to vesting restricted stock units, and he held 1,814,998 shares directly after the transaction.
Innventure, Inc. Executive Chairman Michael Otworth reported a tax-related share disposition. On the vesting of restricted stock units, 218,577 shares of common stock were withheld at a price of $2.80 per share to satisfy tax withholding obligations. After this transaction, he directly owned 3,274,030 shares of Innventure common stock.
Innventure, Inc. files a prospectus supplement updating its Form S-1 prospectus to include a Current Report on Form 8-K dated February 20, 2026.
The supplement attaches the Form 8-K and discloses that on February 16, 2026 Innventure LLC entered into letter employment agreements with Michael Otworth and Dr. John Scott, each converting prior consulting arrangements into at‑will employment while maintaining materially consistent compensation.
Innventure, Inc. files a prospectus supplement to its Form S-1 updating the Prospectus with a Current Report on Form 8-K dated February 20, 2026.
The supplement incorporates employment letter agreements effective February 16, 2026 that convert prior consulting arrangements for Michael Otworth and Dr. John Scott into at‑will employment with Innventure LLC. The filings state the prior consulting agreements were terminated and that base salary, target annual bonus and long‑term equity incentive opportunities remain materially consistent with prior consulting compensation. Shares of common stock trade on Nasdaq under the symbol INV; the closing price cited is $2.80 per share as of February 26, 2026.
Innventure, Inc. filed a prospectus supplement dated February 27, 2026 that incorporates a Form 8-K disclosure dated February 16, 2026 describing letter employment agreements for two named executive officers.
The supplement states that Michael Otworth (Executive Chairman) and Dr. John Scott (Chief Strategy Officer) converted from independent contractor arrangements to at-will employment with Innventure LLC on February 16, 2026, terminating their prior consulting agreements. Each executive’s base salary, target annual bonus opportunity, and long-term equity incentive opportunities will remain materially consistent with prior consulting compensation, and both are eligible to participate in employee benefit plans. The supplement attaches Exhibits 10.1 and 10.2 containing the letter agreements.
Innventure, Inc., through its subsidiary AeroFlexx, announced that Aveda will become the first prestige beauty brand to globally adopt AeroFlexx’s innovative refill packaging. The arrangement is described as a partnership focused on more sustainable, consumer-friendly packaging.
The AeroFlexx refill format is curbside recyclable where HDPE plastic bottles are accepted and uses up to 70% less plastic than two 250ml Aveda bottles. It features a lightweight, integrated airframe structure that supports resealable, controlled refilling while aligning with Aveda’s design-for-recyclability principles.
The new AeroFlexx refill packaging is planned to debut with select best-selling Aveda products beginning early next year. The partnership highlights Aveda’s ongoing focus on responsible, circular packaging and positions AeroFlexx’s technology within a global, prestige beauty portfolio.
Innventure, Inc. director Bruce Brown reported acquiring 8,202 shares of common stock on February 20, 2026. These fully vested shares, valued at $3.83 per share, were granted under the company’s Non-Management Director Compensation Plan in lieu of cash retainers for the fourth quarter of 2025. Following this award, Brown directly holds 42,634 shares of Innventure common stock.
Donnally James O reported acquisition or exercise transactions in this Form 4 filing.
Innventure, Inc. director James O. Donnally received a grant of 7,180 fully vested shares of common stock at $3.83 per share under the company’s Non-Management Director Compensation Plan, in lieu of cash retainers for the fourth quarter of 2025, bringing his direct holdings to 22,305 shares. He also reports indirect interests through the James O. Donnally Revocable Trust and Our-No Family Holdings LP, where he has voting and investment power, and through the Glockner Family Venture Fund, where he has no decision-making authority and disclaims beneficial ownership beyond any pecuniary interest.